Target intelligence / Profile preview

RNA, U1 small nuclear 105, pseudogene (RNU1-105P)

Target
RNU1-105P
Molecular classification
Other, Pseudogene, Non-coding RNA, Small nuclear RNA pseudogene
01

Overview

RNA, U1 small nuclear 105, pseudogene (RNU1-105P) is a human pseudogene corresponding to a U1 small nuclear RNA (snRNA) gene family member[1][4][6]. Pseudogenes such as RNU1-105P are derived from genes that encode functional RNAs but have accumulated mutations rendering them non-functional; thus, this locus does not yield a functional snRNA involved in spliceosomal activity. RNU1-105P lacks the biological activity of canonical U1 snRNA, which normally plays a role in pre-mRNA splicing as a component of the spliceosome. There are no known therapeutic interventions, disease associations, or use as a biomarker or drug target related to RNU1-105P[1][4][6]. **Clarification:** RNU1-105P is a *pseudogene*, not a protein-coding gene, not a receptor, and not a therapeutic target. Pseudogenes are generally *not* targets for drugs, do not have direct biological functions themselves, and are not involved as disease markers unless specified otherwise in the literature, which is not the case for RNU1-105P per available data[1][4][6]. **Summary of issues:** - RNU1-105P is not a true molecular target (e.g., receptor, enzyme, transporter); it is a non-coding RNA pseudogene[1][4][6]. - There is no evidence it has any therapeutic relevance, biological function, disease association, or drug interaction. - It should not be used as a canonical therapeutic target entry.

Other names
RNU1-105P

Beyond the preview

Go deeper on RNA, U1 small nuclear 105, pseudogene (RNU1-105P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 105, pseudogene (RNU1-105P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call